You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 3, September 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of the Oral Fructose Test

Its Use in Determining Patency of Portacaval Shunts

MARVIN M. KIRSH, MD; HERBERT CARES, MD; GEORGE D. ZUIDEMA, MD

AMA Arch Surg. 1964;89(3):508-511.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The ideal test for determining patency of a portacaval shunt would be applicable to all patients, simple to perform, give accurate, consistent results which are easy to interpret, and afford minimal risk to the patient. Many techniques have been utilized which have met these criteria with varying degrees of success.

The direct approach has been the actual visualization of the portal vein by splenoportography or retrograde catheterization of the portal vein via the inferior vena cava. These procedures are not without hazard and require considerable experience to be performed properly.

Measurement of portal circulation time by rectal instillation of ether1 or radioactive sodium,2 or by intravenous injection of labelled isotopes3 or radioactive gases4 have been proposed as methods of determining shunt patency. The end-point obtained by these techniques is vague, however. Consequently there has been a wide variation in results.

The bypassed liver is unable to . . . [Full Text PDF of this Article]


Author Affiliations

ANN ARBOR, MICH

John and Mary R. Markle Scholar in Academic Medicine, United States Public Health Service Career Development Awardee, No. 5K3-AM-13702-03 (Dr. Zuidema).; From the Department of Surgery, University of Michigan Medical School.


Footnotes

Submitted for publication March 18, 1964.

Supported by United States Public Health Service grants-in-aid No. HE-04260-06 and 5MO1-FR-42, supporting the University of Michigan Clinical Research Center, and United States Army Contract No. DA-49-007-MD-1016.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.